CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2016 at 10:00 am PT (1:00 pm ET) at The Westin St. Francis in San Francisco. This presentation will include a review of the company’s goals and guidance. In addition, the company will webcast the Q&A breakout session immediately following its presentation at 10:30 am PT (1:30 pm ET).
